Moxie Dwight

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$2.03M

Insider Activity of Moxie Dwight

According to the SEC Form 4 filings, Moxie Dwight, being in a position of

  1. CLO & GC at Revance Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8125 shares for $40,971,
    over all time since 2021-09-27, has bought 0 shares, and sold 84550 shares for $2.03M.

The largest sale of all time was on 2023-05-15 and amounted to 21401 share of Revance Therapeutics, Inc. for $739,338.

Biography of Moxie Dwight

No biography is available at this moment.

2024-03-18SaleRevance Therapeutics, Inc.
RVNC
CLO & GC
8,125
0.008%
$5.04$40,971-20.04%
2023-09-06SaleRevance Therapeutics, Inc.
RVNC
SVP, GC & Secretary
11,000
0.0126%
$17.06$187,704-64.86%
2023-09-05SaleRevance Therapeutics, Inc.
RVNC
SVP, GC & Secretary
23,853
0.0276%
$17.81$424,920-66.02%
2023-05-15SaleRevance Therapeutics, Inc.
RVNC
SVP, GC & Secretary
21,401
0.0269%
$34.55$739,338-75.34%
2023-03-09SaleRevance Therapeutics, Inc.
RVNC
SVP, GC & Secretary
18,496
0.0233%
$31.59$584,220-45.58%
2021-09-27SaleRevance Therapeutics, Inc.
RVNC
SVP, GC & Secretary
1,675
0.0025%
$30.00$50,250-47.51%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.